VentriPoint Diagnostics Ltd. / Fundamentals
Income statement
- Net revenue
€102.43K - Cost of goods sold
€9.54K - Gross profit
€92.89K - SG&A expenses
€2.32M - R&D expenses
€534.22K - EBITDA
-€2.73M - D&A
€38.02K - EBIT
-€2.75M - Interest expenses
€179.12K - EBT
-€2.94M - Tax expenses
-€51.36K - Net income
-€2.89M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
€110.12K - Changes in working capital
€523.48K - Operating cash flow
-€1.74M - Capex
€2.46 - Other investing cash flow
€0.00 - Net investing cash flow
€0.00 - Total cash dividends paid
€0.00 - Issuance of common stock
€531.94K - Debt repayment
€1.38M - Other financing cash flow
-€166.75K - Net financing cash flow
€1.74M - Foreign exchange effects
-€20.29K - Net change in cash
-€13.75K - Cash at end of period
€216.97K - Free cash flow
-€1.74M
Balance sheet
- Cash and cash equivalents
€216.97K - Cash and short-term investments
€216.97K - Total receivables
€158.12K - Inventory
€0.00 - Other current assets
€66.57K - Total current assets
€441.66K - Property, plant & equipment
€103.74K - Goodwill
€0.00 - Intangible assets
€0.00 - Long-term investments
€0.00 - Other non-current assets
€0.00 - Total non-current assets
€103.74K - Total assets
€545.40K - Accounts payable
€1.19M - Short-term debt
€1.19M - Other current liabilities
€219.14K - Total current liabilities
€2.60M - Long-term debt
€116.49K - Deferred tax liabilities
€0.00 - Other non-current liabilities
€0.00 - Total non-current liabilities
€116.49K - Total liabilities
€2.72M - Common stock
€27.05M - Retained earnings
-€36.53M - Other equity
€28.16K - Total equity
-€2.17M - Total liabilities and shareholders' equity
€545.40K
Company information
- Market capitalization
€14.04M - Employees
0 - Enterprise Value
€21.18M
Company ratios
- Gross margin
-
90.7% Much better than peer group: 42.4% - EBITDA margin
-
-2,663.7% Much better than peer group: -7,972.8% - EBIT margin
-
-2,687.7% Much better than peer group: -12,285.8% - EBT margin
-
-2,867.0% Much better than peer group: -6,618.2% - Net margin
-
-2,816.9% Much better than peer group: -7,940.7% - ROE
-
132.7% Much better than peer group: -229.7% - ROA
-
-529.0% Much better than peer group: -12,725.9% - Asset turnover
-
18.8% Much worse than peer group: 158.6% - FCF margin
-
-1,697.1% Much better than peer group: -21,492.0% - FCF yield
-12.4% - Efficiency ratio
2,763.7% - Net sales per employee
-
€0.00 - Net income per employee
-
€0.00